Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trimethoprim | 2 | 2021 | 15 | 1.500 |
Why?
|
| Sulfadiazine | 2 | 2021 | 24 | 0.930 |
Why?
|
| Animal Care Committees | 2 | 2012 | 4 | 0.800 |
Why?
|
| Hematology | 1 | 2021 | 30 | 0.750 |
Why?
|
| Housing, Animal | 4 | 2020 | 42 | 0.690 |
Why?
|
| Mice | 23 | 2023 | 11700 | 0.640 |
Why?
|
| Choroidal Neovascularization | 3 | 2023 | 32 | 0.630 |
Why?
|
| Gastrointestinal Microbiome | 6 | 2022 | 491 | 0.620 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 260 | 0.600 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 777 | 0.540 |
Why?
|
| Microbiota | 7 | 2022 | 396 | 0.450 |
Why?
|
| Animals | 30 | 2023 | 27203 | 0.440 |
Why?
|
| Animal Experimentation | 1 | 2012 | 7 | 0.430 |
Why?
|
| Wet Macular Degeneration | 2 | 2023 | 25 | 0.420 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 159 | 0.390 |
Why?
|
| Animal Welfare | 2 | 2020 | 41 | 0.390 |
Why?
|
| Mice, Inbred ICR | 2 | 2021 | 73 | 0.370 |
Why?
|
| Animal Husbandry | 2 | 2020 | 26 | 0.360 |
Why?
|
| Research Support as Topic | 1 | 2010 | 82 | 0.350 |
Why?
|
| Neointima | 2 | 2020 | 14 | 0.340 |
Why?
|
| Carotid Artery Injuries | 2 | 2020 | 22 | 0.340 |
Why?
|
| Graft Rejection | 3 | 2022 | 1083 | 0.340 |
Why?
|
| Administration, Oral | 2 | 2021 | 684 | 0.330 |
Why?
|
| Skin Transplantation | 3 | 2022 | 182 | 0.330 |
Why?
|
| Research Design | 1 | 2012 | 594 | 0.320 |
Why?
|
| Medetomidine | 1 | 2008 | 1 | 0.310 |
Why?
|
| Cebus | 1 | 2008 | 19 | 0.310 |
Why?
|
| Ketamine | 1 | 2008 | 25 | 0.310 |
Why?
|
| Anesthesia | 1 | 2008 | 169 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2010 | 389 | 0.260 |
Why?
|
| Skin | 2 | 2019 | 580 | 0.240 |
Why?
|
| Rodentia | 2 | 2022 | 42 | 0.230 |
Why?
|
| Corticosterone | 1 | 2023 | 35 | 0.220 |
Why?
|
| Organ Transplantation | 3 | 2022 | 276 | 0.220 |
Why?
|
| Pest Control | 1 | 2023 | 6 | 0.220 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 190 | 0.220 |
Why?
|
| Vibration | 1 | 2023 | 51 | 0.220 |
Why?
|
| Dust | 2 | 2020 | 26 | 0.220 |
Why?
|
| Bacteria | 2 | 2018 | 468 | 0.210 |
Why?
|
| Risk Assessment | 1 | 2010 | 2285 | 0.210 |
Why?
|
| Mite Infestations | 1 | 2022 | 6 | 0.210 |
Why?
|
| Pyrethrins | 1 | 2022 | 10 | 0.210 |
Why?
|
| Mites | 1 | 2022 | 16 | 0.210 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2020 | 64 | 0.210 |
Why?
|
| Dermatitis | 1 | 2022 | 34 | 0.200 |
Why?
|
| Rectal Prolapse | 1 | 2021 | 9 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 8 | 2022 | 3198 | 0.200 |
Why?
|
| Macular Degeneration | 1 | 2022 | 61 | 0.200 |
Why?
|
| Retinal Diseases | 1 | 2022 | 90 | 0.190 |
Why?
|
| Immunocompetence | 1 | 2020 | 27 | 0.190 |
Why?
|
| Floors and Floorcoverings | 1 | 2020 | 7 | 0.180 |
Why?
|
| Animals, Laboratory | 1 | 2020 | 16 | 0.180 |
Why?
|
| Arterivirus Infections | 1 | 2020 | 4 | 0.180 |
Why?
|
| Lactate dehydrogenase-elevating virus | 1 | 2020 | 7 | 0.180 |
Why?
|
| Weight Gain | 1 | 2021 | 122 | 0.180 |
Why?
|
| Environmental Microbiology | 1 | 2020 | 22 | 0.180 |
Why?
|
| Drug Combinations | 1 | 2020 | 203 | 0.180 |
Why?
|
| Bedding and Linens | 1 | 2019 | 12 | 0.180 |
Why?
|
| Rodent Diseases | 1 | 2019 | 34 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 303 | 0.170 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2343 | 0.170 |
Why?
|
| Diet, High-Fat | 2 | 2022 | 118 | 0.170 |
Why?
|
| Arteritis | 1 | 2018 | 9 | 0.170 |
Why?
|
| Carotid Arteries | 1 | 2020 | 127 | 0.160 |
Why?
|
| Germ-Free Life | 4 | 2021 | 75 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1999 | 190 | 0.160 |
Why?
|
| Diet | 1 | 2021 | 442 | 0.150 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2017 | 46 | 0.140 |
Why?
|
| Constipation | 1 | 2017 | 63 | 0.140 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 235 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2023 | 247 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 2015 | 151 | 0.120 |
Why?
|
| Circadian Clocks | 1 | 2015 | 59 | 0.120 |
Why?
|
| Immunization | 1 | 2014 | 160 | 0.120 |
Why?
|
| Dysbiosis | 1 | 2015 | 77 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 562 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 199 | 0.120 |
Why?
|
| Retroviridae Infections | 1 | 2014 | 48 | 0.120 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 66 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2744 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 67 | 0.110 |
Why?
|
| Allergens | 1 | 2014 | 181 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 118 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2015 | 344 | 0.110 |
Why?
|
| Omentum | 1 | 2013 | 72 | 0.110 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2022 | 12 | 0.110 |
Why?
|
| Choroid | 2 | 2022 | 35 | 0.100 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 181 | 0.100 |
Why?
|
| Visual Acuity | 2 | 2023 | 197 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2013 | 254 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2023 | 421 | 0.090 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2010 | 25 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2023 | 313 | 0.090 |
Why?
|
| Organizational Policy | 1 | 2010 | 55 | 0.090 |
Why?
|
| Inflammation | 1 | 2015 | 961 | 0.080 |
Why?
|
| Male | 9 | 2023 | 41953 | 0.080 |
Why?
|
| Hyperplasia | 2 | 2020 | 152 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 565 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2010 | 226 | 0.080 |
Why?
|
| Restraint, Physical | 1 | 2008 | 28 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 453 | 0.070 |
Why?
|
| Transcriptome | 2 | 2022 | 623 | 0.070 |
Why?
|
| Female | 6 | 2023 | 45687 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2019 | 141 | 0.070 |
Why?
|
| Transplantation, Homologous | 2 | 2022 | 1001 | 0.070 |
Why?
|
| Imidazoles | 1 | 2008 | 151 | 0.070 |
Why?
|
| Mastication | 1 | 2008 | 78 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 759 | 0.070 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 238 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 466 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 927 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 379 | 0.060 |
Why?
|
| Nesting Behavior | 1 | 2023 | 20 | 0.060 |
Why?
|
| Noise | 1 | 2023 | 27 | 0.060 |
Why?
|
| Darkness | 1 | 2022 | 49 | 0.050 |
Why?
|
| Insecta | 1 | 2023 | 49 | 0.050 |
Why?
|
| Body Temperature Regulation | 1 | 2022 | 56 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2019 | 1987 | 0.050 |
Why?
|
| Permethrin | 1 | 2022 | 9 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 111 | 0.050 |
Why?
|
| Retina | 1 | 2023 | 214 | 0.050 |
Why?
|
| Photoperiod | 1 | 2022 | 73 | 0.050 |
Why?
|
| Lidocaine | 1 | 2021 | 64 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 73 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 139 | 0.050 |
Why?
|
| Light | 1 | 2022 | 292 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 1220 | 0.050 |
Why?
|
| Lasers | 1 | 2021 | 107 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 2531 | 0.050 |
Why?
|
| Rectum | 1 | 2021 | 148 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 235 | 0.050 |
Why?
|
| Pasteurellaceae | 1 | 2019 | 5 | 0.040 |
Why?
|
| Helicobacter | 1 | 2019 | 5 | 0.040 |
Why?
|
| Laboratory Animal Science | 1 | 2019 | 6 | 0.040 |
Why?
|
| Caliciviridae Infections | 1 | 2019 | 10 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2019 | 23 | 0.040 |
Why?
|
| Norovirus | 1 | 2019 | 13 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2023 | 376 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 102 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 1999 | 107 | 0.040 |
Why?
|
| Streptozocin | 1 | 1999 | 55 | 0.040 |
Why?
|
| Staphylococcus epidermidis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 129 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1999 | 39 | 0.040 |
Why?
|
| Insulin Infusion Systems | 1 | 1999 | 36 | 0.040 |
Why?
|
| Vascular Patency | 1 | 1999 | 126 | 0.040 |
Why?
|
| C-Peptide | 1 | 1999 | 179 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 1999 | 227 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 46 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 400 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 66 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 1056 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 167 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2019 | 184 | 0.040 |
Why?
|
| Catheterization | 1 | 1999 | 238 | 0.040 |
Why?
|
| Pancreas | 1 | 1999 | 242 | 0.040 |
Why?
|
| Loperamide | 1 | 2017 | 7 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 1999 | 240 | 0.040 |
Why?
|
| Chronic Disease | 1 | 1999 | 948 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2016 | 164 | 0.030 |
Why?
|
| Humans | 6 | 2022 | 88482 | 0.030 |
Why?
|
| Allografts | 1 | 2016 | 177 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 203 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 147 | 0.030 |
Why?
|
| Clostridium | 1 | 2014 | 23 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2014 | 46 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 26 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 77 | 0.030 |
Why?
|
| Insulin | 1 | 1999 | 1153 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 994 | 0.030 |
Why?
|
| Kidney | 1 | 1999 | 1145 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2014 | 109 | 0.030 |
Why?
|
| Azure Stains | 1 | 2013 | 6 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 136 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1086 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 452 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 307 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2013 | 65 | 0.030 |
Why?
|
| Feces | 1 | 2015 | 326 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1642 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 523 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 79 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 342 | 0.030 |
Why?
|
| Graft Survival | 1 | 2016 | 912 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 797 | 0.030 |
Why?
|
| Child, Preschool | 1 | 1999 | 3671 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 685 | 0.030 |
Why?
|
| Colon | 1 | 2015 | 505 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 863 | 0.020 |
Why?
|
| Intestines | 1 | 2014 | 416 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 427 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3029 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 686 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1241 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1427 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 969 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1976 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 8151 | 0.010 |
Why?
|